No Data
No Data
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges
Trending Stocks Today | Longeveron Surges 25% Post-Market
Trending Stocks Today | Aclarion Shoots up 56.72%
Organogenesis Up Over 53%, On Track for Largest Percent Increase Since January 2019 -- Data Talk
Cantor Fitzgerald Maintains Organogenesis(ORGO.US) With Buy Rating, Raises Target Price to $6
Organogenesis Shares Jump After Surprise 4Q Earnings, 2025 Guidance